MARKET

INM

INM

Inmed Pharmaceuticals Inc
NASDAQ
0.8600
0.0000
0.00%
After Hours: 0.8772 +0.0172 +2.00% 19:03 02/20 EST
OPEN
0.8629
PREV CLOSE
0.8600
HIGH
0.8991
LOW
0.8600
VOLUME
11.41K
TURNOVER
--
52 WEEK HIGH
7.98
52 WEEK LOW
0.8500
MARKET CAP
2.51M
P/E (TTM)
-0.2106
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at INM last week (0209-0213)?
Weekly Report · 6d ago
InMed Highlights Q2 Results Amid Cash, Regulatory Pressures
TipRanks · 02/12 11:32
InMed Pharmaceuticals Inc. Q2 BayMedica revenue drops 26% to USD 0.8 million
Reuters · 02/12 11:04
InMed Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
Newsfile · 02/11 22:23
InMed Pharma Q4 R&D expenses USD 0.63 million, down 30%
Reuters · 02/11 22:05
Weekly Report: what happened at INM last week (0202-0206)?
Weekly Report · 02/09 09:31
Weekly Report: what happened at INM last week (0126-0130)?
Weekly Report · 02/02 09:30
Weekly Report: what happened at INM last week (0119-0123)?
Weekly Report · 01/26 09:30
More
About INM
InMed Pharmaceuticals Inc. is a pharmaceutical company. The Company develops a pipeline of small molecule drug candidates targeting the CB1/CB2 receptors. Its InMed Pharma segment is engaged in the research and development of small molecule pharmaceuticals drug candidates. Its BayMedica Commercial segment is engaged in the manufacturing technologies to produce and commercialize bulk rare cannabinoids for sale as ingredients in the health and wellness industry. Its pharmaceutical pipeline consists of three programs, with drug candidates targeting Alzheimer’s disease, dry age-related macular degeneration, and Epidermolysis Bullosa. Its INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Its INM-089 is a small molecule drug candidate being studied for its potential as a treatment for age-related macular degeneration. Its INM-755 is a topical cream which has completed Phase 2 clinical trial studies for the treatment of epidermolysis bullosa.

Webull offers InMed Pharmaceuticals Inc stock information, including NASDAQ: INM real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, INM stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading INM stock methods without spending real money on the virtual paper trading platform.